Showing 561 - 580 results of 99,063 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( 5 ((mm decrease) OR (nn decrease)) ))', query time: 1.49s Refine Results
  1. 561

    Fig 4 - by Matthew C. Kochem (18476069)

    Published 2024
    Subjects:
  2. 562

    Fig 3 - by Matthew C. Kochem (18476069)

    Published 2024
    Subjects:
  3. 563
  4. 564
  5. 565

    GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

    Published 2021
    “…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”
  6. 566
  7. 567
  8. 568
  9. 569
  10. 570
  11. 571

    Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”
  12. 572
  13. 573
  14. 574
  15. 575
  16. 576

    A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

    Published 2015
    “…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”
  17. 577
  18. 578

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…<p>Cell lysates were obtained from THP-1 monocytes exposed to reagents as indicated: Lane 1, vehicle; Lane 2, PARP inhibitor olaparib (5 mM, 24 hr); Lane 3, oxLDL (100 mg/mL, 24 hr) or Lane 4, combination of oxLDL and olaparib. …”
  19. 579
  20. 580